Quest Partners LLC Terns Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 1 shares of TERN stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 104,535
100.0%
Holding current value
$4
Previous $872 Million
100.0%
% of portfolio
0.0%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding TERN
# of Institutions
160Shares Held
83.7MCall Options Held
484KPut Options Held
141K-
Soleus Capital Management, L.P. Greenwich, CT8.14MShares$34 Million3.16% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$31.5 Million1.14% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$28.8 Million7.51% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$23.3 Million1.37% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.75MShares$19.8 Million0.17% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $157M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...